We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
119 hedge funds and large institutions have $341M invested in Anika Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.56% more ownership
Funds ownership: 93.4% → 93.96% (+0.56%)
0% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 43
6% less funds holding
Funds holding: 127 → 119 (-8)
19% less call options, than puts
Call options by funds: $213K | Put options by funds: $264K
29% less capital invested
Capital invested by funds: $483M → $341M (-$142M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Holders
119
Holders Change
-8
Holders Change %
-6.3%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
43
Reduced
43
Closed
20
Calls
$213K
Puts
$264K
Net Calls
-$51K
Net Calls Change
-$51K
Top Buyers
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$23.5M |
| 2 |
Morgan Stanley
New York
|
-$1.75M |
| 3 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$1.66M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.15M |
| 5 |
Millennium Management
New York
|
-$1.09M |
